MDXG (MiMedx Group, Inc)
Insider Trading Activity
Every open-market purchase and sale reported by MDXG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | RICE DOUG | Chief Financial Officer | F | — | — |
| 2026-06-25 | Kimberly Maersk-Moller | Chief Commercial Officer | F | — | — |
| 2026-06-12 | WILLIAM A HAWKINS | Director | A | — | — |
| 2026-06-12 | Tiffany Olson | Director | A | — | — |
| 2026-06-12 | DOROTHY E PUHY | Director | A | — | — |
| 2026-06-12 | JAMES L BIERMAN | Director | A | — | — |
| 2026-06-12 | Todd Newton | Director | A | — | — |
| 2026-03-17 | Kimberly Maersk-Moller | Chief Commercial Officer | F | — | — |
| 2026-03-17 | William Frank Hulse IV | General Counsel and CAO | F | — | — |
| 2026-03-12 | Kimberly Maersk-Moller | Chief Commercial Officer | MIXED | — | — |
| 2026-03-12 | RICE DOUG | Chief Financial Officer | MIXED | — | — |
| 2026-03-12 | William Frank Hulse IV | General Counsel and CAO | MIXED | — | — |
| 2026-03-06 | Kimberly Maersk-Moller | Chief Commercial Officer | A | — | — |
| 2026-03-06 | Joseph H Capper | Chief Executive Officer | A | — | — |
| 2026-03-06 | RICE DOUG | Chief Financial Officer | A | — | — |
| 2026-03-06 | Ricci S Whitlow | Chief Operating Officer | A | — | — |
| 2026-03-06 | William Frank Hulse IV | General Counsel and CAO | A | — | — |
| 2026-02-18 | Ricci S Whitlow | Chief Operating Officer | F | — | — |
| 2025-11-10 | Kimberly Maersk-Moller | Chief Commercial Officer | Sell | — | — |
| 2025-07-07 | RICE DOUG | Chief Financial Officer | F | — | — |
| 2025-06-26 | Kimberly Maersk-Moller | Chief Commercial Officer | F | — | — |
| 2025-06-23 | DOROTHY E PUHY | Director | A | — | — |
| 2025-06-23 | Tiffany Olson | Director | A | — | — |
| 2025-06-23 | JAMES L BIERMAN | Director | A | — | — |
| 2025-06-23 | M KATHLEEN BEHRENS | Director | A | — | — |
| 2025-06-23 | Todd Newton | Director | A | — | — |
| 2025-06-23 | CATO T LAURENCIN | Director | A | — | — |
| 2025-06-23 | WILLIAM A HAWKINS | Director | A | — | — |
| 2025-05-16 | William Frank Hulse IV | General Counsel and CAO | F | — | — |
| 2025-05-05 | Joseph H Capper | Chief Executive Officer | Buy | — | — |
| 2025-04-25 | William Frank Hulse IV | General Counsel and CAO | F | — | — |
| 2025-04-10 | William Frank Hulse IV | General Counsel and CAO | F | — | — |
| 2025-04-03 | Kimberly Maersk-Moller | Chief Commercial Officer | F | — | — |
| 2025-03-20 | Kimberly Maersk-Moller | Chief Commercial Officer | Sell | — | — |
| 2025-03-14 | Kimberly Maersk-Moller | Chief Commercial Officer | Sell | — | — |
| 2025-03-14 | William Frank Hulse IV | General Counsel and CAO | Sell | — | — |
| 2025-03-12 | William Frank Hulse IV | General Counsel and CAO | Sell | — | — |
| 2025-03-05 | RICE DOUG | Chief Financial Officer | A | — | — |
| 2025-03-05 | Joseph H Capper | Chief Executive Officer | A | — | — |
| 2025-03-05 | William Frank Hulse IV | General Counsel and CAO | A | — | — |
| 2025-03-05 | Ricci S Whitlow | Chief Operating Officer | A | — | — |
| 2025-03-05 | Kimberly Maersk-Moller | Chief Commercial Officer | MIXED | — | — |
| 2025-02-18 | Ricci S Whitlow | Chief Operating Officer | Sell | — | — |
| 2024-12-13 | Kimberly Maersk-Moller | Chief Commercial Officer | A | — | — |
| 2024-07-10 | RICE DOUG | Chief Financial Officer | F | — | — |
| 2024-06-06 | JAMES L BIERMAN | Director | A | — | — |
| 2024-06-06 | Todd Newton | Director | A | — | — |
| 2024-06-06 | WILLIAM A HAWKINS | Director | A | — | — |
| 2024-06-06 | Tiffany Olson | Director | A | — | — |
| 2024-06-06 | M KATHLEEN BEHRENS | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 28,195,249 | — |
| — | 10%+ Owner | 22,598,410 | — |
| — | Chairman & CEO | 4,519,935 | — |
| — | Director | 3,338,135 | — |
| — | Chief Executive Officer | 1,711,324 | — |
| — | Director | 1,431,525 | — |
| — | Chief Executive Officer | 904,656 | — |
| — | Director | 769,728 | — |
| — | President and COO | 659,253 | — |
| — | Chief Financial Officer | 656,435 | — |
| — | General Counsel and CAO | 543,195 | — |
| — | Interim CEO | 463,684 | — |
| — | Chief Operating Officer | 462,825 | — |
| — | Director | 446,288 | — |
| — | President, WC & Surgical | 430,072 | — |
| — | Chief Financial Officer | 399,566 | — |
| — | EVP & Chief Strategy Officer | 379,925 | — |
| — | President, Regenerative Med. | 328,168 | — |
| — | Chief Commercial Officer | 309,630 | — |
| — | Director | 263,684 | — |
| — | Director | 254,931 | — |
| — | Chief Financial Officer | 238,594 | — |
| — | SVP, Operations & Procurement | 226,643 | — |
| — | Director | 212,771 | — |
| — | General Counsel and Secretary | 193,247 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MDXG quote page; the site-wide leaderboard is on the insider transactions hub.